Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...

New European Union rules for health technology assessments become effective: Amsterdam, The Netherlands Monday, January 13, 2025, 10:00 Hrs [IST] EMA is ready to support the imple ...

ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi: Our Bureau, Bengaluru Monday, January 13, 2025, 09:00 Hrs [IST] The Authentic ...

Molbio Diagnostics redefines molecular diagnostics with Truenat: Monday, January 13, 2025, 08:00 Hrs [IST] In a world marked by significant healthcare disparities and the rising b ...

KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes: Nandita Vijayasimha, Bengaluru ...

Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] ...

Peethaambaran Kunnathoor, Chennai Monday, January 13, 2025, 08:00 Hrs [IST] ...

Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing: Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] A Par ...

Exporters concerned over delay in getting relief under Section 43B(h) of IT Act: Shardul Nautiyal, Mumbai Monday, January 13, 2025, 08:00 Hrs [IST] India’s pharmaceutical export ...

CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...

FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025: Philadelphia Saturday, January 11, 2025, 17:00 Hrs [IST] FORE Bioth ...

Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea: Milan Saturday, January 11, 2025, 16:00 Hrs [IST] ...